<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665715</url>
  </required_header>
  <id_info>
    <org_study_id>DK-REAKTIV-15</org_study_id>
    <nct_id>NCT02665715</nct_id>
  </id_info>
  <brief_title>Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?</brief_title>
  <official_title>Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amirsalar Samkani</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Roux-en-Y gastric bypass (RYGB) accelerates nutrient delivery to the small intestine causing
      higher peak blood glucose concentration early after meal intake. In the late postprandial
      period (1 1‚ÅÑ2-2 h) nadir blood glucose level is lower compared with before operation. In some
      patients, overt postprandial hypoglycaemia develops, and is typically reported as a
      complication 1-5 years postoperatively, when maximal weight loss has been obtained. The
      pathophysiology of postprandial hypoglycaemia involves inappropriate hyper-secretion of
      insulin associated with exaggerated secretion of the gut hormone glucagon-like peptide-1
      (GLP-1) leading to a mismatch between glucose absorption rate, insulin secretion and whole
      body glucose disposal. We hypothesize that lowering carbohydrate content of meals reduces
      postprandial glucose excursions whereby GLP-1 and insulin secretion is reduced and reactive
      hypoglycemia prevented.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nadir plasma glucose</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak plasma glucose</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to nadir glucose</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to peak glucose</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial incremental glucose area</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial decremental glucose area</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial incremental insulin area</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial incremental GLP-1 area</measure>
    <time_frame>0-240 min, 240-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time below basline glucose concentrations</measure>
    <time_frame>0-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic excursions</measure>
    <time_frame>0-480 min</time_frame>
    <description>Between low carbohydrate meal and standard meal.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Bariatric Surgery (Gastric Bypass)</condition>
  <arm_group>
    <arm_group_label>Low carbohydrate/Standard carbohydrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 Roux-en-Y gastric bypass operated subjects are tested two days with mixed-meal tests. Each studytest day consist of both breakfast and lunch.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard carbohydrate/Low carbohydrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 Roux-en-Y gastric bypass operated subjects are tested two days with mixed-meal tests. Each studytest day consist of both breakfast and lunch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low carbohydrate meals</intervention_name>
    <description>Meal macronutritional energy composition: Carbohydrate 30% Protein 30% Fat 40%</description>
    <arm_group_label>Low carbohydrate/Standard carbohydrate</arm_group_label>
    <arm_group_label>Standard carbohydrate/Low carbohydrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard carbohydrate meals</intervention_name>
    <description>Meal macronutritional energy composition: Carbohydrate 55% Protein 15% Fat 30%</description>
    <arm_group_label>Low carbohydrate/Standard carbohydrate</arm_group_label>
    <arm_group_label>Standard carbohydrate/Low carbohydrate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  RYGB operated patients more than 12 month after operation

          -  Stable in weight for at least 3 months (+/- 3 kg)

          -  Plasma glucose below 3.4 mmol/L after screening with test meal (Fresubin drink) or
             with continuous glucose monitoring

        Exclusion Criteria:

          -  Fasting plasma glucose concentration &gt; 7mmol/L

          -  Critical illness

          -  Hgb &lt; 6.5 mM

          -  Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirstine Bojsen-Moller, MD, Postdoc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sten Madsbad, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinology Research Center, Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <state>Copenhagen</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2016</study_first_submitted>
  <study_first_submitted_qc>January 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>July 20, 2016</last_update_submitted>
  <last_update_submitted_qc>July 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Amirsalar Samkani</investigator_full_name>
    <investigator_title>PhD-Student</investigator_title>
  </responsible_party>
  <keyword>Reactive hypoglycemia</keyword>
  <keyword>Hyperinsulinaemia</keyword>
  <keyword>Diet</keyword>
  <keyword>Glucagon-like Peptide-1</keyword>
  <keyword>Glucagon</keyword>
  <keyword>Peptide YY</keyword>
  <keyword>Ghrelin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucagon</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

